11
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Modelling of serial carcinoembryonic antigen changes in colorectal cancer

, , &
Pages 751-755 | Received 06 Jan 1993, Accepted 26 Jun 1993, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mitchell J. Goldstein & Edith Peterson Mitchell. (2005) Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer. Cancer Investigation 23:4, pages 338-351.
Read now

Articles from other publishers (15)

B Shinkins, J N Primrose, S A Pugh, B D Nicholson, R Perera, T James & D Mant. (2018) Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial. British Journal of Surgery 105:6, pages 658-662.
Crossref
Bethany Shinkins, Brian D Nicholson, Tim James, Indika Pathiraja, Sian Pugh, Rafael Perera, John Primrose & David Mant. (2017) What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial. Health Technology Assessment 21:22, pages 1-60.
Crossref
Bethany Shinkins, Brian D. Nicholson, John Primrose, Rafael Perera, Timothy James, Sian Pugh & David Mant. (2017) The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial. PLOS ONE 12:3, pages e0171810.
Crossref
Brian D Nicholson, Bethany Shinkins, Indika Pathiraja, Nia W Roberts, Tim J James, Susan Mallett, Rafael Perera, John N Primrose & David Mant. (2015) Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database of Systematic Reviews 2015:12.
Crossref
P. Pereira, L. Ghouti, M. Humeau, T. Filleron, J. Selves, R. Guimbaud, N. Carrere & G. Portier. (2015) Récidives pelviennes de cancers du rectum à composante extraluminaleExtra luminal pelvic recurrence from rectal cancer. Oncologie 17:7-8, pages 309-314.
Crossref
Bethany Shinkins, Brian D Nicholson, Timothy J James, John N Primrose & David Mant. (2014) Carcinoembryonic Antigen Monitoring to Detect Recurrence of Colorectal Cancer: How Should We Interpret the Test Results?. Clinical Chemistry 60:12, pages 1572-1574.
Crossref
Irene Grossmann, Charlotte Verberne, Geertruida De Bock, Klaas Havenga, Ido Kema, Joost Klaase, Andrew Renehan & Theo Wiggers. (2011) The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis Paper. Cancers 3:2, pages 2302-2315.
Crossref
O. Schaefer & M. Langer. (2007) Detection of recurrent rectal cancer with CT, MRI and PET/CT. European Radiology 17:8, pages 2044-2054.
Crossref
Farshad Abir, Suraj Alva, Walter E. Longo, Riccardo Audiso, Katherine S. Virgo & Frank E. Johnson. (2006) The postoperative surveillance of patients with colon cancer and rectal cancer. The American Journal of Surgery 192:1, pages 100-108.
Crossref
N. Eche. (2004) Marqueurs des cancers digestifs : côlon–rectum, pancréas, foie. Immuno-analyse & Biologie Spécialisée 19:5, pages 279-285.
Crossref
Walter E Longo & Frank E Johnson. (2002) The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surgical Clinics of North America 82:5, pages 1091-1108.
Crossref
D. E. Nadig, K. S. Virgo, W. E. Longo & F. E. Johnson. 2001. Modern Management of Cancer of the Rectum. Modern Management of Cancer of the Rectum 135 146 .
B. J. Kjeldsen, O. Kronborg, C. Fenger & O. D. Jørgensen. (1997) A prospective randomized study of follow-up after radical surgery for colorectal cancer. British Journal of Surgery 84:5, pages 666-669.
Crossref
Warwick J. Adams & David L. Morris. (2008) CARCINOEMBRYONIC ANTIGEN IN THE EVALUATION OF THERAPY OF PRIMARY AND METASTATIC COLORECTAL CANCER. Australian and New Zealand Journal of Surgery 66:8, pages 515-519.
Crossref
Ole Kronborg. (2006) Optimal follow‐up in colorectal cancer patients: What tests and how often?. Seminars in Surgical Oncology 10:3, pages 217-224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.